文献速递肝病

RNA解旋酶DEAD-box蛋白5通过锚定TSC复合物并抑制mTORC1信号缓解非酒精性脂肪性肝炎进展

RNA helicase DEAD-box protein 5 alleviates nonalcoholic steatohepatitis progression via tethering TSC complex and suppressing mTORC1 signaling.
PubMed 文献 · Hepatology · 2023-04-17

本文研究DEAD-box蛋白5(DDX5)在非酒精性脂肪性肝炎(NASH)中的作用。DDX5在NASH患者、饮食诱导NASH小鼠模型及棕榈酸刺激的肝细胞中表达下调;过表达DDX5可改善肝脏脂肪变性和炎症,而缺失则加重病理。机制上DDX5通过招募TSC1/2复合物至mTORC1抑制其激活,从而改善脂质代谢并减弱NLRP3炎症小体活化;植物化学物hyperforcinol K可直接结合DDX5并阻止其泛素化降解,显著减少NASH小鼠模型的脂质蓄积和炎症。

要点

  • DDX5在NASH患者及多种饮食诱导NASH小鼠模型中表达下调。
  • DDX5过表达改善肝脏脂肪变性和炎症,缺失则加重病理。
  • hyperforcinol K直接结合DDX5并阻止其泛素化降解,减轻NASH小鼠脂质蓄积和炎症。

核心结论

  • DDX5通过招募TSC1/2复合物至mTORC1抑制其激活,改善脂质代谢并减弱NLRP3炎症小体活化,从而缓解NASH进展。
  • hyperforcinol K直接结合DDX5并阻止其经E3泛素连接酶TRIM5介导的泛素化降解,显著减少NASH小鼠模型的脂质蓄积和炎症。

研究设计与样本

  • 研究检测了NASH患者、饮食诱导NASH小鼠模型(高脂饮食、蛋氨酸-胆碱缺乏饮食、胆碱缺乏高脂饮食)、NASH-HCC小鼠模型(二乙基亚硝胺联合高脂饮食)及棕榈酸刺激肝细胞中DDX5的表达。
  • 通过腺相关病毒介导DDX5过表达或缺失观察其对肝脏脂肪变性和炎症的影响,并采用非靶向代谢组学分析机制。

主要发现

  • DDX5在NASH患者、饮食诱导NASH小鼠模型、NASH-HCC小鼠模型及棕榈酸刺激的肝细胞中表达下调。
  • 腺相关病毒介导的DDX5过表达改善肝脏脂肪变性和炎症,而DDX5缺失则加重上述病理。
  • 非靶向代谢组学分析提示DDX5对脂质代谢具有调控作用。
  • DDX5通过招募TSC1/2复合物至mTORC1抑制其激活,改善脂质代谢并减弱NLRP3炎症小体活化。
  • hyperforcinol K直接与DDX5相互作用并阻止其经E3泛素连接酶TRIM5介导的泛素化降解,显著减少NASH小鼠模型的脂质蓄积和炎症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Nonalcoholic fatty liver disease and its progressive form, nonalcoholic steatohepatitis (NASH), are rapidly becoming the top causes of hepatocellular carcinoma (HCC). Currently, there are no approved therapies for the treatment of NASH. DEAD-box protein 5 (DDX5) plays important roles in different cellular processes. However, the precise role of DDX5 in NASH remains unclear. APPROACH AND RESULTS: DDX5 expression was downregulated in patients with NASH, mouse models with diet-induced NASH (high-fat diet [HFD], methionine- and choline-deficient diet, and choline-deficient HFD), mouse models with NASH-HCC (diethylnitrosamine with HFD), and palmitic acid-stimulated hepatocytes. Adeno-associated virus-mediated DDX5 overexpression ameliorates hepatic steatosis and inflammation, whereas its deletion worsens such pathology. The untargeted metabolomics analysis was carried out to investigate the mechanism of DDX5 in NASH and NASH-HCC, which suggested the regulatory effect of DDX5 on lipid metabolism. DDX5 inhibits mechanistic target of rapamycin complex 1 (mTORC1) activation by recruiting the tuberous sclerosis complex (TSC)1/2 complex to mTORC1, thus improving lipid metabolism and attenuating the NACHT-, leucine-rich-repeat (LRR)-, and pyrin domain (PYD)-containing protein 3 inflammasome activation. We further identified that the phytochemical compound hyperforcinol K directly interacted with DDX5 and prevented its ubiquitinated degradation mediated by ubiquitin ligase (E3) tripartite motif protein 5, thereby significantly reducing lipid accumulation and inflammation in a NASH mouse model. CONCLUSIONS: These findings provide mechanistic insight into the role of DDX5 in mTORC1 regulation and NASH progression, as well as suggest a number of targets and a promising lead compound for therapeutic interventions against NASH.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Ye S, Lu W, et al. RNA helicase DEAD-box protein 5 alleviates nonalcoholic steatohepatitis progression via tethering TSC complex and suppressing mTORC1 signaling. Hepatology. 2023. PMID: 35796622. doi:10.1002/hep.32651

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。